We serve Chemical Name:methyl 2-chloro-5-fluoropyridine-4-carboxylate CAS:876919-10-7 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:methyl 2-chloro-5-fluoropyridine-4-carboxylate
CAS.NO:876919-10-7
Synonyms:Methyl 2-chloro-5-fluoroisonicotinate
Molecular Formula:C7H5ClFNO2
Molecular Weight:189.57200
HS Code:
Physical and Chemical Properties:
Melting point:N/A
Boiling point:253.9ºC at 760 mmHg
Density:1.386g/cm3
Index of Refraction:1.511
PSA:39.19000
Exact Mass:188.99900
LogP:1.66070
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like Methyl 2-chloro-5-fluoroisonicotinate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Methyl 2-chloro-5-fluoroisonicotinate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Methyl 2-chloro-5-fluoroisonicotinate Use and application,Methyl 2-chloro-5-fluoroisonicotinate technical grade,usp/ep/jp grade.
Related News: Exceeding impurities in the drug substance may cause the product and its preparation to be recalled. The company receives an FDA warning letter or a CEP certificate suspension, which in turn will cause customer compensation, product recall costs, and asset impairment losses to affect the company’s performance. methyl 2-chloro-5-fluoropyridine-4-carboxylate manufacturer The third-to-market BTK inhibitor is also looking to report top-line results from a front-line trial later this year. Imbruvica could feel more pressure if that study also turns out successful. methyl 2-chloro-5-fluoropyridine-4-carboxylate supplier Biogen research chief Alfred Sandrock said the FDA had painstakingly analyzed its clinical trial data over two years before reaching a conclusion. methyl 2-chloro-5-fluoropyridine-4-carboxylate vendor The third-to-market BTK inhibitor is also looking to report top-line results from a front-line trial later this year. Imbruvica could feel more pressure if that study also turns out successful. methyl 2-chloro-5-fluoropyridine-4-carboxylate factory Exceeding impurities in the drug substance may cause the product and its preparation to be recalled. The company receives an FDA warning letter or a CEP certificate suspension, which in turn will cause customer compensation, product recall costs, and asset impairment losses to affect the company’s performance.
